Evaluation of late rectal toxicity after conformal radiotherapy for prostate cancer

[1]  R. Orecchia,et al.  Sooner or later? Outcome analysis of 431 prostate cancer patients treated with postoperative or salvage radiotherapy. , 2009, International journal of radiation oncology, biology, physics.

[2]  M. Schwaiger,et al.  Effects of Irradiation on the [Methyl-3H]Choline Uptake in the Human Prostate Cancer Cell Lines LNCaP and PC3 , 2008, Strahlentherapie und Onkologie.

[3]  D. Zips,et al.  Prostate Cancer: Biological Dose Considerations and Constraints in Tele- and Brachytherapy , 2007, Strahlentherapie und Onkologie.

[4]  M. Valenti,et al.  Transabdominal Ultrasonography, Computed Tomography and Electronic Portal Imaging for 3-Dimensional Conformal Radiotherapy for Prostate Cancer , 2007, Strahlentherapie und Onkologie.

[5]  Marnix G Witte,et al.  IMRT optimization including random and systematic geometric errors based on the expectation of TCP and NTCP. , 2007, Medical physics.

[6]  X. Li,et al.  Comparison of three accelerated partial breast irradiation techniques: treatment effectiveness based upon biological models. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  Barbara Alicja Jereczek-Fossa,et al.  Evidence-based radiation oncology: definitive, adjuvant and salvage radiotherapy for non-metastatic prostate cancer. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[8]  R. Sweeney,et al.  Single-Institution Results of Primary External-Beam Radiation for the Treatment of T1–T3 Prostate Cancer , 2007, Strahlentherapie und Onkologie.

[9]  Giuseppe Iaccarino,et al.  Relationships between rectal wall dose-volume constraints and radiobiologic indices of toxicity for patients with prostate cancer. , 2007, International journal of radiation oncology, biology, physics.

[10]  Matthias Guckenberger,et al.  Intensity-Modulated Radiotherapy (IMRT) of Localized Prostate Cancer , 2007, Strahlentherapie und Onkologie.

[11]  Matthias Guckenberger,et al.  Influence of Rectum Delineation (Rectal Volume vs. Rectal Wall) on IMRT Treatment Planning of the Prostate , 2006, Strahlentherapie und Onkologie.

[12]  Joos V Lebesque,et al.  Rectal bleeding, fecal incontinence, and high stool frequency after conformal radiotherapy for prostate cancer: normal tissue complication probability modeling. , 2006, International journal of radiation oncology, biology, physics.

[13]  G. Sanguineti,et al.  Does Treatment of the Pelvic Nodes with IMRT Increase Late Rectal Toxicity over Conformal Prostate-Only Radiotherapy to 76 Gy? , 2006, Strahlentherapie und Onkologie.

[14]  P. Georg,et al.  Inverse Planning – a Comparative Intersystem and Interpatient Constraint Study , 2006, Strahlentherapie und Onkologie.

[15]  G. Arcangeli,et al.  A study of the effect of setup errors and organ motion on prostate cancer treatment with IMRT. , 2006, International journal of radiation oncology, biology, physics.

[16]  Michel Bolla,et al.  Guidelines for primary radiotherapy of patients with prostate cancer. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  V. Budach,et al.  Influence of Organ at Risk Definition on Rectal Dose-Volume Histograms in Patients with Prostate Cancer Undergoing External-Beam Radiotherapy , 2006, Strahlentherapie und Onkologie.

[18]  Radhe Mohan,et al.  Cluster model analysis of late rectal bleeding after IMRT of prostate cancer: a case-control study. , 2006, International journal of radiation oncology, biology, physics.

[19]  C. Hess,et al.  A Prospective Three–Dimensional Analysis about the Impact of Differences in the Clinical Target Volume in Prostate Cancer Irradiation on Normal–Tissue Exposure , 2005, Strahlentherapie und Onkologie.

[20]  G. Gustafson,et al.  Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy. , 2005, International journal of radiation oncology, biology, physics.

[21]  B. Lind,et al.  Dose-Response Relations for Anal Sphincter Regarding Fecal Leakage and Blood or Phlegm in Stools after Radiotherapy for Prostate Cancer , 2005, Strahlentherapie und Onkologie.

[22]  M Bolla,et al.  EAU guidelines on prostate cancer. , 2001, European urology.

[23]  F Foppiano,et al.  Fitting late rectal bleeding data using different NTCP models: results from an Italian multi-centric study (AIROPROS0101). , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[24]  Gary Luxton,et al.  Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate. , 2004, International journal of radiation oncology, biology, physics.

[25]  Radhe Mohan,et al.  Characterization of rectal normal tissue complication probability after high-dose external beam radiotherapy for prostate cancer. , 2004, International journal of radiation oncology, biology, physics.

[26]  S. Webb,et al.  Use of artificial neural networks to predict biological outcomes for patients receiving radical radiotherapy of the prostate. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[27]  Roberto Orecchia,et al.  Finding dose-volume constraints to reduce late rectal toxicity following 3D-conformal radiotherapy (3D-CRT) of prostate cancer. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[28]  A. Niemierko,et al.  Methodological issues in radiation dose-volume outcome analyses: summary of a joint AAPM/NIH workshop. , 2002, Medical physics.

[29]  Franca Foppiano,et al.  Relationships between DVHs and late rectal bleeding after radiotherapy for prostate cancer: analysis of a large group of patients pooled from three institutions. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[30]  C. Abbou,et al.  EAU guidelines on prostate cancer. , 2009, European urology.

[31]  G J Kutcher,et al.  Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms. , 2001, International journal of radiation oncology, biology, physics.

[32]  D P Dearnaley,et al.  Individualization of dose prescription based on normal-tissue dose-volume and radiosensitivity data. , 2001, International journal of radiation oncology, biology, physics.

[33]  R. Orecchia,et al.  Analysis of pelvis and abdomenal conformal radiotherapy using TCP and NTCP models , 2001 .

[34]  W. De Gersem,et al.  Radiotherapy of prostate cancer with or without intensity modulated beams: a planning comparison. , 2000, International journal of radiation oncology, biology, physics.

[35]  C. Ling,et al.  Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response. , 2000, International journal of radiation oncology, biology, physics.

[36]  A Fogliata,et al.  Comparative analysis of dose volume histogram reduction algorithms for normal tissue complication probability calculations. , 2000, Acta oncologica.

[37]  Practical considerations in using calculated healthy-tissue complication probabilities for treatment-plan optimization. , 1999, International journal of radiation oncology, biology, physics.

[38]  S. Fosså,et al.  Normal tissue complication probabilities correlated with late effects in the rectum after prostate conformal radiotherapy. , 1999, International journal of radiation oncology, biology, physics.

[39]  L. Gras,et al.  Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 GY) conformal radiotherapy for prostate cancer, using dose-volume histograms. , 1998, International journal of radiation oncology, biology, physics.

[40]  R Calandrino,et al.  Variations of tumor control and rectum complication probabilities due to random set-up errors during conformal radiation therapy of prostate cancer. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[41]  Steve Webb Converting 3d Dose to Biological Outcomes: Tumour Control Probability (Tcp) And Normal-Tissue-Complication Probability (Ntcp) , 1997 .

[42]  S. Webb The Physics of Conformal Radiotherapy: Advances in Technology , 1997 .

[43]  M M Urie,et al.  Conformal irradiation of the prostate: estimating long-term rectal bleeding risk using dose-volume histograms. , 1996, International journal of radiation oncology, biology, physics.

[44]  L. Verhey,et al.  The "critical volume tolerance method" for estimating the limits of dose escalation during three-dimensional conformal radiotherapy for prostate cancer. , 1996, International journal of radiation oncology, biology, physics.

[45]  M van Herk,et al.  Variation in volumes, dose-volume histograms, and estimated normal tissue complication probabilities of rectum and bladder during conformal radiotherapy of T3 prostate cancer. , 1995, International journal of radiation oncology, biology, physics.

[46]  M. Oldham,et al.  Comparison of treatment techniques for conformal radiotherapy of the prostate using dose-volume histograms and normal tissue complication probabilities. , 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[47]  S Webb,et al.  A comparison of conventional 'forward planning' with inverse planning for 3D conformal radiotherapy of the prostate. , 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[48]  T. Pajak,et al.  Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) , 1995, International journal of radiation oncology, biology, physics.

[49]  M G Kahn,et al.  Objective evaluation of radiation treatment plans. , 1993, Proceedings. Symposium on Computer Applications in Medical Care.

[50]  P. Rubin,et al.  Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706. , 1991, International journal of radiation oncology, biology, physics.

[51]  R. Mohan,et al.  Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations. , 1991, International journal of radiation oncology, biology, physics.

[52]  J. Purdy,et al.  Three-dimensional treatment planning considerations for prostate cancer. , 1991, International journal of radiation oncology, biology, physics.

[53]  M. Goitein,et al.  Tolerance of normal tissue to therapeutic irradiation. , 1991, International journal of radiation oncology, biology, physics.

[54]  C. Burman,et al.  Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method. , 1989, International journal of radiation oncology, biology, physics.

[55]  J. Lyman Complication probability as assessed from dose-volume histograms. , 1985, Radiation research. Supplement.

[56]  D. McShan,et al.  Quality assurance review program for radiotherapy in a cooperative group , 1981 .